[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

OGEN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $47,752.20

Oragenics Insider Trading History Chart

Oragenics Share Price & Price History

^$3.70

▲ +0.1 (2.78%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Oragenics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/9/2022	Robert C Koski	Director	Sell	813	$12.00	$9,756.00	21,910
11/29/2022	Robert C Koski	Director	Sell	3,333	$11.40	$37,996.20	26,274
6/17/2022	Fred Telling	Director	Buy	168	$17.40	$2,923.20	16,833
5/23/2022	Fred Telling	Director	Buy	58	$17.40	$1,009.20	15,354
5/20/2022	Fred Telling	Director	Buy	1,095	$16.80	$18,396.00	15,295
5/18/2022	Fred Telling	Director	Buy	255	$15.60	$3,978.00	13,253
3/30/2022	Fred Telling	Director	Buy	2,079	$21.60	$44,906.40
3/29/2022	Michael O'keefe Sullivan	CFO	Buy	333	$21.00	$6,993.00
1/13/2021	Joseph Hernandez	Major Shareholder	Sell	4,291	$48.00	$205,968.00	67,066
1/11/2021	Joseph Hernandez	Major Shareholder	Sell	7,365	$46.20	$340,263.00	67,066
1/6/2021	Joseph Hernandez	Major Shareholder	Sell	16,666	$36.00	$599,976.00	67,066
1/4/2021	Joseph Hernandez	Major Shareholder	Sell	2,933	$31.20	$91,509.60	67,066
12/22/2020	Robert C Koski	Director	Sell	5,166	$25.80	$133,282.80
12/2/2020	Joseph Hernandez	Major Shareholder	Sell	83,333	$24.60	$2,049,991.80	70,000

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Oragenics (NYSEAMERICAN:OGEN)

2.07% of Oragenics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Oragenics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/11/2023	Renaissance Technologies LLC	12,722	$42K	0.0%	-24.3%	0.649%
5/16/2023	Geode Capital Management LLC	12,453	$41K	0.0%	-98.3%	0.636%
5/12/2023	Renaissance Technologies LLC	16,799	$55K	0.0%	-94.2%	0.858%
5/12/2023	BlackRock Inc.	22,148	$73K	0.0%	-98.3%	1.131%
2/13/2023	Renaissance Technologies LLC	288,398	$30K	0.0%	+24.4%	14.722%
2/13/2023	Geode Capital Management LLC	747,027	$78K	0.0%	-0.3%	38.133%
1/11/2023	Sara Bay Financial	1,271,281	$0.13M	0.1%	-36.7%	1.084%
8/15/2022	Millennium Management LLC	128,733	$45K	0.0%	+591.6%	0.111%
8/13/2022	Renaissance Technologies LLC	209,600	$73K	0.0%	+116.5%	0.180%
5/16/2022	State Street Corp	495,563	$0.17M	0.0%	+8.1%	0.426%
5/13/2022	Renaissance Technologies LLC	96,800	$33K	0.0%	+388.9%	0.083%
2/14/2022	GSA Capital Partners LLP	410,944	$0.18M	0.0%	+150.6%	0.353%
1/14/2022	Sara Bay Financial	2,008,117	$0.90M	0.3%	+99.2%	1.725%
11/15/2021	GSA Capital Partners LLP	163,954	$0.10M	0.0%	N/A	0.141%
11/12/2021	Renaissance Technologies LLC	894,205	$0.57M	0.0%	+254.1%	0.768%
9/17/2021	Virtu Financial LLC	65,456	$46K	0.0%	+212.9%	0.056%
8/17/2021	Bridgeway Capital Management LLC	140,000	$99K	0.0%	-68.8%	0.121%
8/16/2021	State Street Corp	454,325	$0.32M	0.0%	N/A	0.393%
8/13/2021	Renaissance Technologies LLC	252,564	$0.18M	0.0%	N/A	0.218%
8/13/2021	Geode Capital Management LLC	731,304	$0.52M	0.0%	+36.6%	0.632%
8/13/2021	Vanguard Group Inc.	5,031,450	$3.55M	0.0%	+11.3%	4.351%
5/18/2021	Private Wealth Advisors	56,824	$52K	0.0%	N/A	0.049%
5/18/2021	Citadel Advisors LLC	370,521	$0.34M	0.0%	+77.2%	0.320%
5/18/2021	Jane Street Group LLC	33,015	$30K	0.0%	N/A	0.029%
5/12/2021	Northern Trust Corp	181,383	$0.17M	0.0%	+205.4%	0.157%
5/12/2021	Geode Capital Management LLC	535,519	$0.49M	0.0%	+131.3%	0.463%
5/10/2021	GSA Capital Partners LLP	48,767	$44K	0.0%	-52.1%	0.042%
5/7/2021	BlackRock Inc.	1,581,463	$1.43M	0.0%	+124.1%	1.368%
2/24/2021	Virtu Financial LLC	164,679	$74K	0.0%	-38.7%	0.213%
2/4/2021	GSA Capital Partners LLP	101,799	$46K	0.0%	+98.0%	0.132%
1/15/2021	Sara Bay Financial	1,008,117	$0.45M	0.2%	-23.5%	1.304%
12/11/2020	Virtu Financial LLC	268,510	$0.15M	0.0%	N/A	0.347%
11/6/2020	GSA Capital Partners LLP	51,404	$30K	0.0%	N/A	0.084%
8/31/2020	Bridgeway Capital Management Inc.	140,000	$97K	0.0%	N/A	0.229%
7/30/2020	Integrated Wealth Concepts LLC	80,645	$56K	0.0%	N/A	0.146%
7/21/2020	Sara Bay Financial	1,321,117	$1.07M	0.6%	N/A	2.386%
5/13/2020	Third Security LLC	4,612,166	$2.68M	0.6%	+197.9%	9.999%
2/14/2020	UBS Group AG	65,845	$34K	0.0%	+73.6%	0.143%
2/13/2020	Renaissance Technologies LLC	145,100	$76K	0.0%	N/A	0.315%
2/10/2020	Barclays PLC	335,538	$0.18M	0.0%	+11.7%	0.727%
2/4/2020	Virtu Financial LLC	98,902	$52K	0.0%	+180.1%	0.214%
11/27/2019	Sabby Management LLC	618,822	$0.33M	0.2%	-50.9%	1.342%
11/27/2019	Barclays PLC	300,400	$0.16M	0.0%	+49.9%	0.651%
8/16/2019	CVI Holdings LLC	703,075	$0.35M	0.3%	-79.3%	1.525%
2/14/2019	Barclays PLC	135,400	$0.12M	0.0%	+95.9%	0.460%
2/8/2019	BlackRock Inc.	705,824	$0.61M	0.0%	+82,549.2%	2.398%
1/16/2019	Virtu Financial LLC	138,233	$0.12M	0.0%	+297.9%	0.470%
5/2/2018	Third Security LLC	1,548,166	$2.69M	0.2%	-90.0%	25.421%

Data available starting January 2016

Oragenics, Inc., a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

Today's Range

Now: $3.70

$3.59

$3.70

50 Day Range

MA: $3.41

$2.94

$4.18

52 Week Range

Now: $3.70

$2.60

$12.54

Volume

7,946 shs

Average Volume

15,937 shs

Market Capitalization

$9.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.53

Who are the company insiders with the largest holdings of Oragenics?: Oragenics' top insider shareholders include:
Robert C Koski (Director)
Fred Telling (Director)
Michael O'keefe Sullivan (CFO)
Learn More about top insider investors at Oragenics.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

OGEN Insider Trading

Oragenics Insider Trading History Chart

Oragenics Share Price & Price History

Oragenics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Oragenics (NYSEAMERICAN:OGEN)

Institutional Buying and Selling by Quarter

Oragenics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Oragenics?